HPR127 Examine the Use of Real-World Evidence To Support FDA Decision-Making for New Drug Applications and Biologics License Applications From 2021 to 2022
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.2358
https://www.valueinhealthjournal.com/article/S1098-3015(24)02572-5/fulltext
Section Title :
Section Order :
10604
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)02572-5&doi=10.1016/j.jval.2024.03.2358